目的 探究慢性萎缩性胃炎患者消化内科临床治疗效果.方法 选取2017年2月至2018年2月来本院进行慢性萎缩性胃炎治疗的患者共96例,按照来院的前后顺序分成对照组和观察组,每组48例,对照组采用常规治疗方法,观察组在对照组基础上给予替普瑞酮.观察两组患者的治疗效果及不良反应发生率.结果 观察组患者的病理评分优于对照组(P＜0.05);观察组患者的住院时间为(6.65±0.85)d,对照组患者的住院时间为(13.54±2.74)d,两组比较差异有统计学意义(P＜0.05);观察组患者的治疗有效率为95.83％,对照组为77.08％,差异有统计学意义(P＜0.05).结论 慢性萎缩性胃炎疾病自身具有一定的特殊性,在开展治疗时应有针对性的选择治疗药物,替普瑞酮是一种有效的药物,将其应用到慢性萎缩性胃炎患者治疗中,有助于优化患者的病理评分,降低住院时间,提升临床治疗效果.%Objective To explore the clinical effect of chronic atrophic gastritis in department of gastroenterology.Methods A total of 96 patients with chronic atrophic gastritis treated in our hospital from February 2017 to February 2018 were selected and were divided into the control group and the observation group according to the order of the hospital,48 cases in each group.The control group were given routine treatment,and the observation group was given teprenone on the basis of the control group.The therapeutic effect and the rate of adverse reactions of the two groups were observed.Results The pathological score of the patients in the observation group was better than that in the control group (P＜0.05);the time of hospitalization in the observation group was.shorter than that in the control group [(6.65±0.85)d vs.(13.54±2.74)d] (P＜0.05);the effective rate of clinical treatment in the observation group was higher than that in the control group (95.83％ vs.77.08％) (P＜0.05).Conclusions Chronic atrophic gastritis has certain particularity,it should be targeted in the treatment of chronic atrophic gastritis.Tepradone is an effective drug,it can be used in the treatment of chronic atrophic gastritis patients.It is helpful to optimize the pathological score of patients,reduce the time of hospitalization,and improve the clinical treatment effect.
展开▼
